REVIEW article

Front. Psychiatry

Sec. ADHD

Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1597559

Adult ADHD and Comorbid Anxiety and Depressive Disorders: a review of Etiology and treatment

Provisionally accepted
Xinyu  FuXinyu Fu1Weige  WuWeige Wu2Yuru  WuYuru Wu1Xiaofu  LiuXiaofu Liu1Rongchuan  WuRongchuan Wu1Wanting  LiangWanting Liang1Yun  LiYun Li2*
  • 1The School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian Province, China
  • 2Department of Psychiatry, Xiamen Xianyue Hospital, Xiamen, Fujian Province, China

The final, formatted version of the article will be published soon.

1Objective: ADHD, or Attention-Deficit/Hyperactivity Disorder, is a neurodevelopmental disorder that is known for its high degree of heterogeneity. It often coexists with other psychiatric diseases, especially anxiety and depression. This article reviews recent studies to explore the etiology of comorbid anxiety and depressive disorders in adults with ADHD, analyzing the factors contributing to this elevated comorbidity rate from several perspectives. Additionally, we explore potential directions for future research in this field.2Recent Findings: ADHD exhibits a high comorbidity rate with anxiety and depressive disorders, due to overlapping and interacting symptoms. Individuals with two or more comorbid conditions often experience increased disease burden, prolonged illness duration, and diminished treatment efficacy. The underlying causes of comorbid anxiety and depression in ADHD patients are highly complex and can be understood from multiple dimensions, including genetics, neurobiology, neurocognition, and neuroimaging. This complexity poses significant challenges for clinical diagnosis and treatment. Currently, the management of ADHD patients with concurrent depression or anxiety may involve pharmaceutical interventions combined with non-pharmacological strategies, including psychotherapy (e.g., cognitive-behavioral therapy, CBT) and digital therapeutics. For patients with comorbid illnesses, these intergrated approaches have demonstrated significant improvements in symptom relief and quality of life enhancement.3Summary: ADHD is a highly heterogeneous disorder with a significant comorbidity rate. Recent research has elucidated the pathogenetic mechanisms of ADHD comorbid with depression and anxiety disorders from multiple perspectives. To improve patient functioning, enhance their quality of life, and guide more effective treatments, Further studies are needed to investigate the underlying causes of these comorbid conditions.

Keywords: Adult ADHD, Comorbidity, Anxiety and depressive disorders, Treatment, etiology

Received: 21 Mar 2025; Accepted: 15 May 2025.

Copyright: © 2025 Fu, Wu, Wu, Liu, Wu, Liang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yun Li, Department of Psychiatry, Xiamen Xianyue Hospital, Xiamen, Fujian Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.